MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue
· Financial Post
“We ended 2025 stronger, with 8% revenue growth supported by 43% year over year growth in our international medical cannabis business and a robust platform designed for regulated markets,” said Greg Hunter, CFO and Interim CEO of MediPharm Labs. Read More
Visit betsport.cv for more information.